-
Taojin Oral GLP-1 Weight Loss Drug: Pfizer Bets on "Small Molecules" at Risk, "Oral Peptides" Opportunity Comes?
On December 9th, Science and Technology Innovation Board Daily reported (Reporter Xu Hong) that "the market value of overseas leading companies has skyrocketed" and "A-share related sectors have been ...